• 027104

    The Efficacy of Photodynamic Therapy in Combination with Chemoradiation in Glioblastoma


    Constantinos Hadjipanayis


    Introduction: 5-ALA, recently FDA approved for GBM fluorescence-guided surgery (FGS), was studied in a rodent photodynamic therapy (PDT) model due to its preferential uptake by GBM cells and conversion to the photosensitizing metabolite, protoporphyrin IX (PpIX). In this experiment, the efficacy of 5-ALA PDT in an experimental GBM model in combination with chemoradiation (CRT) was studied.

    Objective: Discuss the use of 5-ALA PDT for targeting GBM tumors due to the selective uptake of 5-ALA and production of protoporphyrin IX (PpIX).

    Discuss the toxicity of 5-ALA PDT in a rodent glioma model.

    Discuss the antitumor effect of 5-ALA PDT in combination with chemoradiation.

    Methods: A safety study was performed in healthy mice, which underwent intracranial 5-ALA (200mg/kg IP) PDT (20J, 635nm). An efficacy study was performed on an invasive, EGFRvIII-expressing radioresistant orthotopic GBM mouse model using 5-ALA PDT, and/or fractionated CRT (5mg/kg TMZ IP; 3Gyx2 whole-brain). Tumor volume quantification was performed through serial MRI volumetric measurements, and the rodents were monitored for signs of tumor growth.

    Results: Healthy mice undergoing 5-ALA PDT did not show any short- or long-term side effects. In the efficacy study, the mean tumor volume in the control group at day 14 was 154.5 ± 65.4mm3, and in the 5-ALA PDT-only group at day 21 was 114.3 ± 102.9mm3. At day 28, the mean tumor volumes for the CRT-only group and 5-ALA PDT + CRT group were 197.5 ± 82.7mm3 and 68.3 ± 86.7mm3, respectively.

    Conclusions: 5-ALA PDT is a safe procedure in rodents. A marked decrease in tumor growth rate was observed after the combination of 5-ALA PDT + CRT therapy in a therapy-resistant GBM rodent model. These observations form the basis for further exploration of the efficacy of PDT combination therapy in the treatment of GBM.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site here. Privacy Policy